Skip to content

Penn Center for Innovation

  • Inventors
    • Disclose Your Invention
    • Commercializing Innovation
  • Entrepreneurs
    • PCI Startup Portfolio
    • PCI Ventures
    • Penn I-Corps
    • Penn and Greater Philadelphia’s Entrepreneurial Ecosystem & Resources
  • Partners
    • Search Penn Technologies
    • Corporate Alliances
    • Licensing
    • Partner with PCI
  • About
    • Contact PCI
    • Events
    • News
    • Metrics and Reports
    • PCI Fellows Program
    • Who We Are
  • Home

Spark ‘very encouraged’ by gene therapy data, targets 2021 for pivotal study

Posted on July 20, 2020

Spark Therapeutics expects to begin patient dosing next year in a pivotal study for its next gene therapy candidate.

The experimental gene therapy is being developed as a treatment for hemophilia A.

Read More on the Philadelphia Business Journal

Posted in School of Medicine, StartupsTagged: External Stories

3600 Civic Center Blvd
9th Floor
Philadelphia, PA 19104

(215) 898-9591
pciinfo@pci.upenn.edu

  • Disclaimer
  • Copyright
  • Privacy Policy
  • Report Accessibility Issues & Get Help
  • Social Media Disclaimer